Molecular imaging of disease with targeted contrast ultrasound imaging

Yoichi Inaba, Jonathan Lindner

    Research output: Contribution to journalArticle

    33 Citations (Scopus)

    Abstract

    To enhance clinical care for patients, methods for noninvasive imaging of specific disease-related molecular changes are being developed to expand and improve diagnostic capabilities. These new techniques are used in research programs to characterize pathophysiology and as a surrogate end point for therapeutic efficacy. Molecular imaging with contrast-enhanced ultrasound relies on the detection of microbubbles or other acoustically active particulate agents that are targeted to and retained at sites of disease. This review describes the progress that has been made in the development and testing of methods for contrast ultrasound molecular imaging with a specific focus on cardiovascular disease. Specific topics addressed include probe development, detection methods, and specific biologic processes that are important in clinical cardiovascular medicine and that have been targeted with microbubble contrast agents.

    Original languageEnglish (US)
    Pages (from-to)140-148
    Number of pages9
    JournalTranslational Research
    Volume159
    Issue number3
    DOIs
    StatePublished - Mar 2012

    Fingerprint

    Molecular imaging
    Molecular Imaging
    Microbubbles
    Ultrasonography
    Ultrasonics
    Imaging techniques
    Clinical Medicine
    Contrast Media
    Medicine
    Patient Care
    Cardiovascular Diseases
    Biomarkers
    Testing
    Research
    Therapeutics

    Keywords

    • ACS
    • acute coronary syndrome
    • ECG
    • electrocardiography
    • phosphatidylserine
    • PS
    • vascular cellular adhesion molecule
    • VCAM

    ASJC Scopus subject areas

    • Medicine(all)
    • Biochemistry, medical
    • Public Health, Environmental and Occupational Health

    Cite this

    Molecular imaging of disease with targeted contrast ultrasound imaging. / Inaba, Yoichi; Lindner, Jonathan.

    In: Translational Research, Vol. 159, No. 3, 03.2012, p. 140-148.

    Research output: Contribution to journalArticle

    @article{044bf1998e8d4ad5b47322311689e2ea,
    title = "Molecular imaging of disease with targeted contrast ultrasound imaging",
    abstract = "To enhance clinical care for patients, methods for noninvasive imaging of specific disease-related molecular changes are being developed to expand and improve diagnostic capabilities. These new techniques are used in research programs to characterize pathophysiology and as a surrogate end point for therapeutic efficacy. Molecular imaging with contrast-enhanced ultrasound relies on the detection of microbubbles or other acoustically active particulate agents that are targeted to and retained at sites of disease. This review describes the progress that has been made in the development and testing of methods for contrast ultrasound molecular imaging with a specific focus on cardiovascular disease. Specific topics addressed include probe development, detection methods, and specific biologic processes that are important in clinical cardiovascular medicine and that have been targeted with microbubble contrast agents.",
    keywords = "ACS, acute coronary syndrome, ECG, electrocardiography, phosphatidylserine, PS, vascular cellular adhesion molecule, VCAM",
    author = "Yoichi Inaba and Jonathan Lindner",
    year = "2012",
    month = "3",
    doi = "10.1016/j.trsl.2011.12.001",
    language = "English (US)",
    volume = "159",
    pages = "140--148",
    journal = "Translational Research",
    issn = "1931-5244",
    publisher = "Mosby Inc.",
    number = "3",

    }

    TY - JOUR

    T1 - Molecular imaging of disease with targeted contrast ultrasound imaging

    AU - Inaba, Yoichi

    AU - Lindner, Jonathan

    PY - 2012/3

    Y1 - 2012/3

    N2 - To enhance clinical care for patients, methods for noninvasive imaging of specific disease-related molecular changes are being developed to expand and improve diagnostic capabilities. These new techniques are used in research programs to characterize pathophysiology and as a surrogate end point for therapeutic efficacy. Molecular imaging with contrast-enhanced ultrasound relies on the detection of microbubbles or other acoustically active particulate agents that are targeted to and retained at sites of disease. This review describes the progress that has been made in the development and testing of methods for contrast ultrasound molecular imaging with a specific focus on cardiovascular disease. Specific topics addressed include probe development, detection methods, and specific biologic processes that are important in clinical cardiovascular medicine and that have been targeted with microbubble contrast agents.

    AB - To enhance clinical care for patients, methods for noninvasive imaging of specific disease-related molecular changes are being developed to expand and improve diagnostic capabilities. These new techniques are used in research programs to characterize pathophysiology and as a surrogate end point for therapeutic efficacy. Molecular imaging with contrast-enhanced ultrasound relies on the detection of microbubbles or other acoustically active particulate agents that are targeted to and retained at sites of disease. This review describes the progress that has been made in the development and testing of methods for contrast ultrasound molecular imaging with a specific focus on cardiovascular disease. Specific topics addressed include probe development, detection methods, and specific biologic processes that are important in clinical cardiovascular medicine and that have been targeted with microbubble contrast agents.

    KW - ACS

    KW - acute coronary syndrome

    KW - ECG

    KW - electrocardiography

    KW - phosphatidylserine

    KW - PS

    KW - vascular cellular adhesion molecule

    KW - VCAM

    UR - http://www.scopus.com/inward/record.url?scp=84857341073&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84857341073&partnerID=8YFLogxK

    U2 - 10.1016/j.trsl.2011.12.001

    DO - 10.1016/j.trsl.2011.12.001

    M3 - Article

    C2 - 22340763

    AN - SCOPUS:84857341073

    VL - 159

    SP - 140

    EP - 148

    JO - Translational Research

    JF - Translational Research

    SN - 1931-5244

    IS - 3

    ER -